• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Bioadaptives Inc
CaliberCos Inc. - Class A Common Stock
Channel Therapeutics Corporation Common Stock
Charlottes Web Holdings Inc
China Pharma Holdings, Inc. Common Stock
Data Storage Corporation - Common Stock
Deepmarkit Corp
Dime Community Bancshares, Inc. - Common Stock
FINANCIAL SEL
First Reliance Bncshs Inc
Freedom Holding Corp. - Common Stock
Global X Social Media ETF
Medical Care Technologies Inc
Monarch Cement CO
Mongolian Mining Corp
Naturalshrimp Incorporated
Netlist, Inc. - Common Stock
Nuburu, Inc. Common Stock
Omineca Mining & Metals Ltd
Oramed Pharmaceuticals Inc. - Common Stock
PLUS THERAPEUTICS, Inc. - Common Stock
Paylocity Holding Corporation - Common Stock
Peer To Peer Network
Planet Resource Reco
Predictiv Ai Inc
SI-BONE, Inc. - Common Stock
SRM Entertainment, Inc. - Common Stock
Sage Group ADR
Salazar Resources Ltd Ord
State Street SPDR Portfolio Long Term Corporate Bond ETF
Supremex Inc
Vanguard FTSE Dev All Cap Na Idx
Vanguard Industrials ETF
Vivos Therapeutics, Inc. - Common Stock
iShares iBonds Dec 2026 Term Treasury ETF
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bright Minds Biosciences Inc (CSE:DRUG)

73.03 -3.51 (-4.59%)
Delayed Quote Updated: 9:48 AM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bright Minds Biosciences Inc

News headline image
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
September 30, 2026
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
May 26, 2026
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
January 09, 2026
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
March 04, 2025
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
February 24, 2025
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
January 07, 2025
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
November 21, 2024
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
November 04, 2024
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
October 21, 2024
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models
October 16, 2024
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events
October 03, 2024
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th
September 19, 2024
From Bright Minds Biosciences
Via GlobeNewswire
News headline image
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences
October 05, 2022
A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effects as a near-death experience (NDE). The... 
Via PressReach
Topics Supply Chain
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences
October 05, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking... 
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap